ESSA Pharma Inc. (EPIX)

3.1501 +0.0501 (+1.616%)

IEX Real-Time Price

August 17, 2018 EST.

NASDAQ Capital Market : Healthcare

Prev Close 3.1

Price Open 3.1

Volume: 1,750

Avg Volume: 6,158

Market Cap: 18.2M

P/E Ratio -0.44

52 Wk Range 2-12.74



EPIX Short Interest Statistics


Report Date
Float Share
Short Interest
Short Ratio
Short % to Float

2018-07-31
5.78M
3,044
0.36
0.05%

2018-07-13
5.78M
6,035
0.50
0.10%

2018-06-29
5.78M
4,056
0.26
0.07%

2018-06-15
5.78M
13,158
0.72
0.23%




EPIX Earning Report


Report Date
Fiscal Period
Announce Time
Estimated EPS(#)
Actual EPS
Surprise Dollar

2018-05-14
Q2 2018
N/A
-0.40 (1)
-0.83
-0.43

2018-02-13
Q1 2018
N/A
0.00 (0)
-0.07
0.00

2017-12-11
Q4 2017
N/A
0.00 (0)
-0.09
0.00

2017-08-14
Q3 2017
N/A
-0.17 (2)
-0.16
0.01

News

ESSA Pharma reports Q3 results (2018-08-14 07:09 SeekingAlpha)

ESSA Pharma (NASDAQ: EPIX ): Q3 EPS of -$0.50 More news on: ESSA Pharma, Inc., Earnings news and commentary, Healthcare stocks news, , Read more …

 

ESSA Pharma Provides Corporate Update and Reports Financial Results for Fiscal Third Quarter Ended June 30, 2018 (2018-08-14 07:00 PR Newswire)

HOUSTON and VANCOUVER , Aug. 14, 2018 /PRNewswire/ -ESSA Pharma Inc. ("ESSA" or the "Company") (TSX-V: EPI, NASDAQ: EPIX), a pharmaceutical company focused on developing novel therapies for the treatment of prostate cancer, today provided a corporate update and reported financial …

 


Statistics

Shares Outstanding: 5.78M

Top 15 Institution Percent: N/A

Price To Sales: N/A

Price To Book: 1.60

Revenue: N/A

Gross Profit: N/A

Cash: 5.83M

Debt: 16.02M

Return On Assets: -85.61

Return On Equity: -263.06

Profit Margin: N/A

Price History

Beta: 0.80

50-day Moving Avg: 3.62

200-day Moving Avg: 4.07

YTD Change: -33.82

5-day Change: 1.13

1-month Change: -17.32

3-month Change: -10.51

6-month Change: -21.25

1-year Change: -53.68

Revenue Per Share: 0.00

Revenue Per Employee: 0.00



Dividend

Dividend Yield: -

EX-Dividend Date: -

Dividend Rate: -


Company Profile

Name: ESSA Pharma Inc.

Exchange: NASDAQ Capital Market

Industry: Drug Manufacturers

Sector: Healthcare

Website: http://www.essapharmaceuticals.com

ESSA Pharma Inc is a pharmaceutical company. The company is in preclinical stage, focused on the development of small molecule drugs for the treatment of castration-resistant prostate cancer.